Reproductive Sciences

, Volume 19, Issue 4, pp 391–399 | Cite as

Effects of Preeclamptic Plasma on Potassium Currents of Human Umbilical Vein Endothelial Cells

  • Wattana B. WatanapaEmail author
  • Wuttinan Theerathananon
  • Pravit Akarasereenont
  • Kitirat Techatraisak


Endothelial cell (EC) dysfunction in preeclampsia (PE) may be mediated by humoral factors secreted by placenta, thereby affecting the EC vasoactive compound production. Possible targets of these factors include potassium channels, which are important in EC membrane potential control, calcium influx, and vasoactive compound release. Alterations in potassium channel function may thus contribute to the pathogenesis of PE. The present study compared the effects of 10% plasma from PE, normal pregnant (NP), or nonpregnant women (NS) on potassium currents of human umbilical vein ECs (HUVECs), using whole-cell patch clamp technique, with HUVECs in conventional culture medium (10% fetal bovine serum) as controls. Cells of all groups were similar in morphology and whole-cell capacitance. The fraction of cells with inward rectifier potassium channel (IRK) current in PE plasma (41.2%) was significantly lower than those in NP and NS plasmas (76.9% and 59.1%, respectively), although the IRK current density was similar among groups. The outward current components included the calcium-sensitive potassium channels (KCa) and were partially blocked by 100 nmol/L apamin and 200 nmol/L iberiotoxin. The fraction with outward current in PE plasma (100%) was significantly higher than those in NP and NS plasmas (76.9% and 81.8%). The findings indicate inhibition of IRK expression by PE plasma in HUVEC culture, while KCa expression may be facilitated probably as a compensatory response to diminished IRK. These data suggest that potassium channels may be a target of the pathogenic factor/factors in the plasma of patients with PE and may play roles in the pathogenesis of this condition.


hypertensive disorder of pregnancy inward rectifier potassium channel calcium-sensitive potassium channels 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    World Health Organization International Collaborative Study of Hypertensive Disorder of Pregnancy. Geographic variation in the incidence of hypertension. Am J Obstet Gynecol. 1998;158(1):80–83.CrossRefGoogle Scholar
  2. 2.
    ACOG. Diagnosis and management of preclampsia and eclampsia. ACOG Pract Bull. 2002;33(1):1–14.Google Scholar
  3. 3.
    World Health Organization. World Health Report: Make Every Mother, and Child Count. Geneva: World Health Org., 2005.Google Scholar
  4. 4.
    VanWijk MJ, Kublickiene K, Boer K, VanBavel E. Vascular function in preeclampsia. Cardiovasc Res. 2000;47(1):38–48.CrossRefGoogle Scholar
  5. 5.
    Noris M, Perico N, Remuzzi G. Mechanisms of disease: preeclampsia. Nat Clin Pract Nephrol. 2005;1(2):98–114.PubMedCrossRefPubMedCentralGoogle Scholar
  6. 6.
    Wang A, Rana S, Karumanchi SA. Preeclampsia: the role of angiogenic factors in its pathogenesis. Physiology. 2009;24(3):147–158.PubMedCrossRefPubMedCentralGoogle Scholar
  7. 7.
    Khalil RA, Crews JK, Novax L, Kassab S, Granger JP. Enhanced vascular activity during inhibition of nitric oxide synthesis in pregnant rats. Hypertension. 1998;31(5):1065–1069.PubMedCrossRefPubMedCentralGoogle Scholar
  8. 8.
    Roberts JM, Taylor RN, Musci TJ, Rodgers GM, Hubel CA, McLaughlin MK. Preeclampsia: an endothelial cell disorder. Am J Obstet Gynecol. 1989;161(5):1200–1204.PubMedCrossRefPubMedCentralGoogle Scholar
  9. 9.
    Wang J, Trudinger B. Endothelial cell dysfunction in preeclampsia. J Nephrol. 1998;11(2):53–56.PubMedPubMedCentralGoogle Scholar
  10. 10.
    Gilbert JS, Ryan MJ, LaMarca BB, Sedeek M, Murpht SR, Granger JP. Pathophysiology of hypertension during preeclampsia: linking placental ischemia with endothelial dysfunction. Am J Physiol Heart Circ Physiol. 2008;294(2):H541–H550.PubMedCrossRefPubMedCentralGoogle Scholar
  11. 11.
    Myatt L, Webster RP. Vascular biology of preeclampsia. J Thromb Heamatost. 2009;7(3):375–384.CrossRefGoogle Scholar
  12. 12.
    Chambers JC, Fusi L, Malik IS, Haskard DO, De Swiet M, Kooner JS. Association of maternal endothelial dysfunction with preeclampsia. JAMA. 2001;285(12):1607–1612.PubMedCrossRefPubMedCentralGoogle Scholar
  13. 13.
    Germain JM, Romanik MC, Guerra I, et al. Endothelial dysfunction: a link among preeclampsia, recurrent pregnancy loss, and future cardiovascular events? Hypertens. 2007;49(1):90–95.CrossRefGoogle Scholar
  14. 14.
    Agatisa PK, Ness RB, Roberts JM, Costantino JP, Kuller LH, Mclaughlin MK. Impairment of endothelial function in women with a history of preeclampsia: an indicator of cardiovascular risk. Am J Physiol Heart Circ Physiol. 2004;286(4):H1389–H1393.PubMedCrossRefPubMedCentralGoogle Scholar
  15. 15.
    Baker PN, Davidge ST, Barankiewic ZJ, Roberts JM. Plasma of preeclamptic women stimulates and then inhibits endothelial prostacyclin. Hypertension. 1996;27(1):56–61.PubMedCrossRefPubMedCentralGoogle Scholar
  16. 16.
    Pinto A, Sorrentino R, Sorrentino P, et al. Endothelial-derived relaxing factor released by endothelial cells of human umbilical vessels and its impairment in pregnancy-induced hypertension. Am J Obstet Gynecol. 1991;164(2):507–513.PubMedCrossRefPubMedCentralGoogle Scholar
  17. 17.
    Rodgers GM, Taylor RN, Roberts JM. Preeclampsia is associated with a serum factor cytotoxic to human endothelial cell. Am J Obstet Gynecol. 1998;159(4):908–914.CrossRefGoogle Scholar
  18. 18.
    Scalera F, Schlembach D, Beinder E. Production of vasoactive substances by human umbilical vein endothelial cells after incubation with serum from preeclamptic patients. Eur J Obstet Gynecol Reprod Biol. 2001;99(2):172–178.PubMedCrossRefPubMedCentralGoogle Scholar
  19. 19.
    Smarason AK, Sargent IL, Redman CW. Endothelial cell proliferation is suppressed by plasma but not serum from women with preeclampsia. Am J Obstet Gynecol. 1996;174(2):787–793.PubMedCrossRefPubMedCentralGoogle Scholar
  20. 20.
    Tsukimori K, Maeda H, Shingu M, Koyanagi T, Nobunaga M, Nakano H. Possible mechanism of vascular damage in preeclampsia. J Human Hypertens. 1994;8(3):177–180.Google Scholar
  21. 21.
    Maynard SE, Min JY, Merchan J, et al. Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J Clin Invest. 2003;111(5):649–658.PubMedPubMedCentralCrossRefGoogle Scholar
  22. 22.
    Nilius B, Droogmans G. Ion channels and their functional role in vascular endothelium Physiol Rev. 2001;81(4):1415–1459.PubMedCrossRefPubMedCentralGoogle Scholar
  23. 23.
    Kamouchi M, Mamin A, Droogmans G, Nilius B. Nonselective cation channels in endothelial cells derived from human umbilical vein. J Membr Biol. 1999;169(1):29–38.PubMedCrossRefPubMedCentralGoogle Scholar
  24. 24.
    Nilius B, Schwartz G, Oike M, Droogmans G. Histamine-activated, non-selective cation currents and Ca2+ transients in endothelial cells from human umbilical vein. Pflugers Arch. 1993;424(3–4):285–293.PubMedCrossRefPubMedCentralGoogle Scholar
  25. 25.
    Steinert JR, Wyatt AW, Poston L, Jacob R, Mann GE. Preeclampsia is associated with altered Ca2+ regulation and NO production in human fetal venous endothelial cells. FASEB J. 2002;16(7):721–723.PubMedCrossRefPubMedCentralGoogle Scholar
  26. 26.
    Köhler R, Schönfelder G, Hopp H, Distler A, Hoyer J. Stretch-activated cation channel in human umbilical vein endothelium in normal pregnancy and in preeclampsia. J Hypertens. 1998;16(8):1149–1156.PubMedCrossRefPubMedCentralGoogle Scholar
  27. 27.
    Keichi M, Hiroshi O, Hirouki K, Masaharu I, Keizo O. Ca++ oscillation in endothelial cell and preclampsia. Lancet. 1998;351(9114):1490–1491.Google Scholar
  28. 28.
    Akarasereenont P. Regulation and Pharmacology of the Inducible Cyclooxygenase (COX-2) [Ph.D. Thesis in Pharmacology]. London, UK: University of London; 1995.Google Scholar
  29. 29.
    Jaffe EA, Nachman RL, Becker CG, Minick CR. Culture of human endothelial cells derived from umbilical veins, identification by morphologic and immunologic criteria. J Clin Invest. 1973;52(11):2745–2756.CrossRefPubMedPubMedCentralGoogle Scholar
  30. 30.
    Hamill OP, Marty A, Neher E, Sakmann B, Sigworth FJ. Improved patch-clamp techniques for high resolution current recording from cells and cell-free membrane patches. Pflugers Arch. 1981;391(2):85–100.PubMedCrossRefPubMedCentralGoogle Scholar
  31. 31.
    Jacobs ER, Cheliakine C, Gebremedhin D, Birks EK, Davies PF, Harder DR. Shear activated channels in cell-attached patches of cultured bovine aortic endothelial cells. Pflugers Arch. 1995;431(1):129–131.PubMedCrossRefPubMedCentralGoogle Scholar
  32. 32.
    Kamouchi M, Vandenbremt K, Eegermont J, Droogmans G, Nilius B. Modulation of inwardly rectifying potassium channels in cultured bovine pulmonary artery endothelial cells. J Physiol (Lond). 1997;507(pt 3):545–556.CrossRefGoogle Scholar
  33. 33.
    Himmel HM, Rauen U, Ravens U. Microvascular endothelial cells from human omentum lack an inward rectifier K+ current. Physiol Res. 2001;50(6):547–555.PubMedPubMedCentralGoogle Scholar
  34. 34.
    Watanapa WB, Chanwongse K, Akarasereenont P, Techatrisak K. Comparison of endothelial K channels in preeclampsia and normal pregnancy. Siriraj Hosp Gaz. 2003;55(suppl 1):173–174.Google Scholar
  35. 35.
    Chiang HT, Wu SN. Inhibition of large-conductance calcium-activated potassium channels by 2-methoxyestradiol in cultured vascular endothelial (HUV-EC-C) cells. J Membr Biol. 2001;182(3):203–212.PubMedCrossRefPubMedCentralGoogle Scholar
  36. 36.
    Wu SN, Jan CR, Li HF, Chen SA. Stimulation of large-conductance calcium-activated potassium channels by Evan Blue in cultured endothelial cells of human umbilical vein. Biochem Biophysic Res Comm. 1999;254(3):666–674.CrossRefGoogle Scholar
  37. 37.
    Zhang H, Inazu M, Weir B, Daniel E. Endothelin-1 inhibits inward rectifier potassium channels and activates nonspecific cation channels in cultured endothelial cells. Pharmacology. 1994;49(1):11–22.PubMedCrossRefPubMedCentralGoogle Scholar
  38. 38.
    Bychkov R, Pieper K, Ried C, et al. Hydrogen peroxide, potassium currents, and membrane potential in human endothelial cells. Circulation. 1999;99(13):1719–1725.PubMedCrossRefPubMedCentralGoogle Scholar
  39. 39.
    Kuhlmann CRW, Schäfer M, Li F, et al. Modulation of endothelial Ca2+-activated K+ channels by oxidized LDL and its contribution to endothelial proliferation. Cardiovasc Res. 2003;60(3):626–634.PubMedCrossRefPubMedCentralGoogle Scholar
  40. 40.
    Ahmad S, Ahmed A. Elevated placental soluble vascular endothelial growth factor receptor-1 inhibits angiogenesis in preeclampsia. Circ Res. 2004;95(9):884–891.PubMedPubMedCentralCrossRefGoogle Scholar
  41. 41.
    Wang Y, Gu Y, Zhang Y, Lewis DF. Evidence of endothelial dysfunction in preeclampsia: decreased endothelial nitric oxide synthase expression is associated with increased cell permeability in endothelial cells from preeclampsia. Am J Obstet Gynecol. 2004;190(3):817–824.PubMedCrossRefPubMedCentralGoogle Scholar
  42. 42.
    Takacs P, Green KL, Nikaeo A, Kauma SW. Increased vascular endothelial cell production of interleukin-6 in severe preeclampsia. Am J Obstet Gynecol. 2003;188(3):740–744.PubMedCrossRefPubMedCentralGoogle Scholar
  43. 43.
    Greer IA, Lyall F, Perera T, Boswell F, Macara LM. Increased concentrations of cytokines interleukin-6 and interleukin-1 receptor antagonist in plasma of women with preeclampsia: a mechanism for endothelial dysfunction? Obstet Gynecol. 1994;84(6):937–940.PubMedPubMedCentralGoogle Scholar
  44. 44.
    Shibuya M. Vascular endothelial growth factor receptor-1 (VEGFR-1/Flt-1): a dual regulator for angiogenesis. Angiogenesis. 2006;9(4):225–230.PubMedCrossRefPubMedCentralGoogle Scholar
  45. 45.
    Zhou Y, McMaster M, Woo K, et al. Vascular endothelial growth factor ligands and receptors that regulate human cytotrophoblast survival are dysregulated in severe preeclampsia and hemolysis, elevated liver enzymes, and low platelets syndrome. Am J Pathol. 2002;160(4):1405–1423.PubMedPubMedCentralCrossRefGoogle Scholar
  46. 46.
    Levine RJ, Maynard SE, Qian C, et al. Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med. 2004;350(7):672–683.PubMedPubMedCentralCrossRefGoogle Scholar
  47. 47.
    McKeeman GC, Ardill JE, Caldwell CM, Hunter AJ, McClure N. Soluble vascular endothelial growth factor receptor-1 (sFlt-1) is increased throughout gestation in patients who have preeclampsia develop. Am J Obstet Gynecol. 2004;191(4):1240–1246.PubMedCrossRefPubMedCentralGoogle Scholar
  48. 48.
    Wathen KA, Tuutti E, Stenman UH, et al. Maternal serum-soluble vascular endothelial growth factor receptor-1 in early pregnancy ending in preeclampsia or intrauterine growth retardation. J Clin Endocrinol Metab. 2006;91(1):180–184.PubMedCrossRefPubMedCentralGoogle Scholar
  49. 49.
    Sandrim VC, Palei ACT, Metzger IF, Gomes VA, Cavalli RC, Tanus-Santos JE. Nitric oxide formation is inversely related to serum levels of antiangiogenic factors soluble FMS-like tyrosine kinase-1 and soluble endogline in preeclampsia. Hypertens. 2008; 52(2):402–407.CrossRefGoogle Scholar
  50. 50.
    Hewett PW, Murray JC, Price EA, Watts ME, Woodcock M. Isolation and characterization of microvessel endothelial cells from human mammary adipose tissue. In Vitro Cell Dev Biol. 1993;29(4):325–331.CrossRefGoogle Scholar
  51. 51.
    Nilius B, Schwarz G, Oike M, Droogmans G. Histamine-activated, non-selective cation currents and Ca21 transients in endothelial cells from human umbilical vein. Pflügers Arch. 1993;424(3–4):285–293.Google Scholar

Copyright information

© Society for Reproductive Investigation 2012

Authors and Affiliations

  • Wattana B. Watanapa
    • 1
    Email author
  • Wuttinan Theerathananon
    • 1
  • Pravit Akarasereenont
    • 2
  • Kitirat Techatraisak
    • 3
  1. 1.Department of Physiology, Faculty of Medicine Siriraj HospitalMahidol UniversityBangkokThailand
  2. 2.Department of Pharmacology, Faculty of Medicine Siriraj HospitalMahidol UniversityBangkokThailand
  3. 3.Department of Obstetrics–Gynecology, Faculty of Medicine Siriraj HospitalMahidol UniversityBangkokThailand

Personalised recommendations